A

Axsome Therapeutics
D

AXSM

90.720
USD
-2.71
(-2.90%)
مغلق
حجم التداول
0
الربح لكل سهم
-5
العائد الربحي
-
P/E
-14
حجم السوق
4,396,506,751
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.520
    (-2.99%)
    16.900 USD
    AMGN
    AMGN
    -7.11
    (-2.67%)
    258.81 USD
    BIIB
    BIIB
    -3.790
    (-2.52%)
    146.820 USD
    B
    BMRN
    -2.570
    (-3.82%)
    64.670 USD
    I
    INCY
    -1.820
    (-2.62%)
    67.550 USD
    L
    LGND
    -5.890
    (-4.89%)
    114.510 USD
    REGN
    REGN
    -25.38
    (-3.43%)
    714.50 USD
    S
    SRPT
    -5.630
    (-4.47%)
    120.200 USD
    VRTX
    VRTX
    -21.90
    (-4.67%)
    447.46 USD
    المزيد
الأخبار

العنوان: Axsome Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.